Hennion & Walsh Asset Management, Inc. Procept Bio Robotics Corp Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.06 Billion
- Q3 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 5,922 shares of PRCT stock, worth $566,083. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,922
Previous 4,649
27.38%
Holding current value
$566,083
Previous $284,000
66.9%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
267Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$463 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$333 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$147 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$119 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$113 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.26B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...